MEHMET SELMAN ONTAN

Dr. MEHMET SELMAN ONTAN

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 May 2023 in Clinical Endocrinology
Verified
Journal Article
Open access
YLYingying Luo
Yingying Luo
RHRaad A. Haddad
Raad A. Haddad
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
AEAbdel Wahab Jalal Eldin
Abdel Wahab Jalal Eldin
MAMohammed Abu‐Rumaileh
Mohammed Abu‐Rumaileh
EOElif A. Oral
Elif A. Oral
Objective: For patients with obesity and diabetes, bariatric surgery can lead to the remission of both diseases. However, the possible impact of diabetes on the magnitude of weight loss outcomes after bariatric surgery has not been precisely quantified.Research Design and Methods: Data from Michigan Bariatric Surgery Cohort (MI‐BASiC) was extracted to examine the effect of baseline diabetes on weight loss outcomes. Consecutive patients older than 18 years of age undergoing gastric bypass (GB) or sleeve gastrectomy (SG) for obesity at University of Michigan between January 2008 and November 2013 were included. Repeated measures analysis was used to determine if diabetes was a predictor of weight loss outcomes over 5 years postsurgery.Results: Out of the 714 included patients, 380 patients underwent GB [mean BMI 47.3 ± 0.4 kg/m2, diabetes 149 (39.2%)] and 334 SG [mean BMI 49.9 ± 0.5 kg/m2, diabetes 108 (32.3%)]. Multivariable repeated measures analysis showed, after adjusting for covariates, that individuals with diabetes had a significantly lower percentage of total (p = .0023) and excess weight loss (p = .0212) compared to individuals without diabetes.Conclusions: Our data demonstrate that patients with diabetes undergoing bariatric surgery would experience less weight loss than patients without diabetes.

24 February 2024 in Psychogeriatrics
Verified
Journal Article
Closed access
KSKübra Altunkalem Seydi
Kübra Altunkalem Seydi
DKDERYA KAYA
DERYA KAYA
IYIdil Yavuz
Idil Yavuz
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
FDFatma Sena DOST
Fatma Sena DOST
AIAhmet Turan ISIK
Ahmet Turan ISIK

3 September 2020 in Applied Neuropsychology: Adult
Verified
Journal Article
Closed access
DKDERYA KAYA
DERYA KAYA
NENeziha Erken
Neziha Erken
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
ZAZekiye Sultan Altun
Zekiye Sultan Altun
AIAhmet Turan ISIK
Ahmet Turan ISIK
Applause sign (AS) was shown to be an indicator of frontal subcortical dysfunction in many neurodegenerative diseases. Idiopathic normal pressure hydrocephalus (INPH) is one of those in which frontosubcortical disconnection can be displayed. We aimed to examine the presence of AS in the elderly patients with INPH and its possible diagnostic role in the frontal dysfunction commonly seen in the disease. Sixty-six patients diagnosed with probable INPH, 32 with behavioral variant of frontotemporal dementia (bvFTD) and 325 healthy elderly subjects were included in this cross-sectional and retrospective study. AS was evaluated with the clapping test. Patients with INPH were further assessed with frontal assessment battery (FAB), Stroop test, verbal fluency test and clock drawing test (CDT). The concentration of total amyloid-β 42 (Aβ42), Aβ40, total (t) tau and phosphorylated (p)-tau proteins were also measured in the cerebrospinal fluid (CSF). AS was observed in all groups (40% in bvFTD, 28.8% in INPH, 1.2% in controls, respectively). It was significantly more frequent in patients with bvFTD and INPH as compared to the controls (p < 0.001, for each). The frequency was similar in the patients with bvFTD and INPH (p = 0.802). Significant differences were found between the AS(+) and (−) INPH patients with regards to FAB, Stroop test-errors and verbal fluency test, except for the CSF proteins. AS can be used as a simple, useful and rapid clinical test that investigates executive dysfunction in elderly patients with INPH in both inpatient and outpatient settings.

4 May 2023 in Applied Neuropsychology: Adult
Verified
Journal Article
Closed access
FMFeyza Mutlay
Feyza Mutlay
DKDERYA KAYA
DERYA KAYA
EBEsra Ates Bulut
Esra Ates Bulut
BSBurcu Akpınar Söylemez
Burcu Akpınar Söylemez
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
AIAhmet Turan ISIK
Ahmet Turan ISIK
The Lewy Body Composite Risk Score (LBCRS) has been developed to increase the sensitivity and specificity of the diagnosis attributable to Lewy body pathology outside of specialty centers. We aimed to assess the validity and reliability of the Turkish version of the LBCRS in patients with dementia with Lewy Bodies (DLB) and investigate the discriminative power of the test in Turkish patients with Alzheimer's disease (AD) and DLB, and control group. The sample population (n = 512) comprised DLB (n = 113), DLB-Mild Cognitive Impairment (MCI)(n = 12), AD (n = 42), AD-MCI (n = 21), and control group (n = 324). A significant group difference was observed in the Turkish version of the LBCRS scores of the five groups (p < .001). The Cronbach's α value was 0.82 (95% CI: 0.799-0.868). The test-retest reliability score of the scale was r = 0.94 and p < .001. The subscales of the LBCRS (motor and nonmotor subdomains of the disease) were determined to explain 65.961% of the total variance with an eigenvalue >1. In patients with DLB, the cutoff score of ≥3 showed sensitivity (92%) and specificity (81%) (area under the curve [AUC] = 0.883, 95% CI: 0.815-0.951), p < .001) compared with the AD. Compared to the control group, the cutoff score of ≥3 showed a sensitivity of 98% and specificity of 97% (AUC = 0.994, 95% CI: 0.989-0.999, p < .001). The Turkish version of LBCRS permits accurate diagnosis of DLB with high sensitivity and specificity. Also, it can be useful to inform the caregivers regarding the course of the disease during the follow-up.

30 April 2021 in Geriatrik Bilimler Dergisi
Verified
Journal Article
Closed access
PDF file
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
ÖDÖzge Dokuzlar
Özge Dokuzlar
Amaç: Osteoporoz ilerleyen yaşla sıklığı artan, çok sayıda morbidite, mortalite ve artan sağlık harcamalarına yol açan bir sorundur. Homosistinüri hastalarında erken yaşta görülen osteoporoz serum homosistein düzeyi ile osteoporoz arasında ilişki olabileceğini düşündürmüştür. Bu çalışmanın amacı, yaşlı erişkinlerde serum homosistein düzeyi ile osteoporoz arasında herhangi bir ilişki olup olmadığının araştırılmasıdır.Gereç ve Yöntemler: Çalışmaya 65 yaş ve üzeri dosyalarında eş zamanlı dual enerji X-ray absorbsiyometri (DEXA) ve serum homosistein seviyesi olan 168 hasta dahil edildi. Hastaların dosyalarında yer alan demografik veriler, DEXA ölçümleri, serum homosistein düzeyi ve laboratuvar analizleri kaydedildi. Retrospektif ve kesitsel bir çalışma olarak dizayn edildi. Bulgular: Katılımcıların yaş ortalaması 75,79±7,40 yıl ve %74,4’ü kadın idi. 67 hastada osteoporoz, 80 hastada osteopeni saptandı. Kontrol, osteopeni ve osteoporoz gruplarında serum homosistein düzeyleri sırası ile 15,01±5,84, 15,42±7,09 ve 15,61±7,88 mmol/L idi. Vitamin B12, Folat, Vitamin D ve TSH düzeyleri gruplar arasında anlamlı fark yoktu. Gruplar arasında yaş, cinsiyet ve vücut kitle indekslerinin karıştırıcı etkileri ortadan kaldırıldıktan sonra artmış serum homosistein düzeyleri ile osteoporoz arasında anlamlı ilişki saptandı (OR:1,114; p<0,05). Diğer sonuçlarda ise istatistiksel anlamlı bir değişiklik olmadı.Sonuç: Yüksek serum homosistein düzeylerinin yaşlı erişkinlerde sık ve önemli bir sorun olan osteoporoz riskini artırdığı saptanmıştır. Bu sonuçların desteklenmesi ve nedenlerinin aydınlatılması için prospektif çalışmalara ihtiyaç duyulmaktadır.

8 February 2023 in BMJ Supportive & Palliative Care
Verified
Journal Article
Closed access
PDF file
MOMEHMET SELMAN ONTAN
MEHMET SELMAN ONTAN
AIAhmet Turan ISIK
Ahmet Turan ISIK
An 85-year-old female patient who did not take any hypokalaemic medication was admitted to the geriatrics outpatient clinic with complaints of feeding problems and abdominal distension for 3 days. Medications on admission were donepezil 10 mg/day, escitalopram …